Cargando…

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research

BACKGROUND: The central role of prostate-specific antigen (PSA) testing in the diagnosis of prostate cancer leads to the possibility that observational studies that report associations between risk factors and prostate cancer could be affected by detection bias. This study aims to investigate whethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Littlejohns, Thomas J., Travis, Ruth C., Key, Tim J., Allen, Naomi E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147810/ https://www.ncbi.nlm.nih.gov/pubmed/27693812 http://dx.doi.org/10.1016/j.canep.2016.09.010

Ejemplares similares

UK Biobank: opportunities for cardiovascular research
por: Littlejohns, Thomas J, et al.
Publicado: (2019)

Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
por: Perez-Cornago, Aurora, et al.
Publicado: (2017)

Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
por: Perez-Cornago, Aurora, et al.
Publicado: (2020)

Association between coeliac disease and cardiovascular disease: prospective analysis of UK Biobank data
por: Conroy, Megan, et al.
Publicado: (2023)

Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
por: Fry, Anna, et al.
Publicado: (2017)

Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies
por: Perez-Cornago, Aurora, et al.
Publicado: (2022)

The advantages of UK Biobank's open‐access strategy for health research
por: Conroy, M., et al.
Publicado: (2019)

Physical activity in relation to circulating hormone concentrations in 117,100 men in UK Biobank
por: Watts, Eleanor L., et al.
Publicado: (2021)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

Apparent latent structure within the UK Biobank sample has implications for epidemiological analysis
por: Haworth, Simon, et al.
Publicado: (2019)

Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank study
por: Papier, Keren, et al.
Publicado: (2021)

Circulating insulin‐like growth factor‐I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank
por: Watts, Eleanor L., et al.
Publicado: (2020)

Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank
por: Mentzer, Alexander J., et al.
Publicado: (2022)

Assessing agreement between different polygenic risk scores in the UK Biobank
por: Clifton, Lei, et al.
Publicado: (2022)

Human Cytomegalovirus and Risk of Incident Cardiovascular Disease in United Kingdom Biobank
por: Hamilton, Elizabeth M, et al.
Publicado: (2021)

Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels
por: Kobayashi, Minoru, et al.
Publicado: (2023)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
por: Young, Grace J, et al.
Publicado: (2017)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
por: Cho, Hyungseok, et al.
Publicado: (2022)

Associations of intakes of total protein, protein from dairy sources, and dietary calcium with risks of colorectal, breast, and prostate cancer: a prospective analysis in UK Biobank
por: Watling, Cody Z., et al.
Publicado: (2023)

Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank
por: Yeh, Tian-Shin, et al.
Publicado: (2023)

Diet and colorectal cancer in UK Biobank: a prospective study
por: Bradbury, Kathryn E, et al.
Publicado: (2020)

New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders
por: Bešević, Jelena, et al.
Publicado: (2022)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity
por: Mattsson, Johanna M., et al.
Publicado: (2014)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
por: Chavan, Sushant V., et al.
Publicado: (2014)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
por: Flores-Fraile, María-Carmen, et al.
Publicado: (2020)

Emergency personnel neuroticism, health and lifestyle: A UK Biobank study
por: Mutambudzi, M, et al.
Publicado: (2019)

Exploring Health in the UK Biobank: Sociodemographic, Psychosocial, Lifestyle and Environmental Factors
por: Mutz, Julian, et al.
Publicado: (2021)

Challenges of linking to routine healthcare records in UK Biobank
por: Adamska, Ligia, et al.
Publicado: (2015)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Combining machine learning with Cox models to identify predictors for incident post-menopausal breast cancer in the UK Biobank
por: Liu, Xiaonan, et al.
Publicado: (2023)

UK Biobank: a globally important resource for cancer research
por: Conroy, Megan C., et al.
Publicado: (2022)

Dietary assessment in UK Biobank: an evaluation of the performance of the touchscreen dietary questionnaire
por: Bradbury, Kathryn E., et al.
Publicado: (2018)

Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements
por: McJimpsey, Erica L.
Publicado: (2016)

Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
por: Filella, Xavier, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m2r3pu0u01okvrmmhvr6fuqd7q